Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma.

Tonn, Torsten; Corman, Victor M; Johnsen, Matthias; Richter, Anja; Rodionov, Roman N; Drosten, Christian; Bornstein, Stefan R

Tonn, Torsten; Corman, Victor M; Johnsen, Matthias; Richter, Anja; Rodionov, Roman N; Drosten, Christian; Bornstein, Stefan R.

Tonn T; Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Corman VM; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North East, D-01307 Dresden, Germany.
Johnsen M; Charité-Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
Richter A; German Centre for Infection Research, Berlin, Germany.
Rodionov RN; Institute for Transfusion Medicine, German Red Cross Blood Donation Service North East, D-01307 Dresden, Germany.
Drosten C; Charité-Universitätsmedizin Berlin Institute of Virology, Berlin, Germany.
Bornstein SR; German Centre for Infection Research, Berlin, Germany.

Lancet Microbe ; 1(2): e63, 2020 06.

Article in English | MEDLINE | ID: covidwho-728935

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral/therapeutic use; COVID-19/therapy; Humans; Immunization, Passive; Immunoglobulin M; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Lancet Microbe Year: 2020 Document Type: Article Affiliation country: S2666-5247(20)30037-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google